Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. The company’s lead program focuses on psilocybin with psychotherapy for patients with cancer related demoralization, anxiety and depression. Reset Pharma has established a highly experienced biotech development team and has a Scientific Advisory Board of leading experts in psychiatry, oncology and psychedelics.
Location: United States, New York
Employees: 11-50
Total raised: $11.12M
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Iter Inves... | iterinvest... |
| - | PsyMed Ven... | psymed.ven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.02.2022 | Series A | $11.12M | - |